The Office of HIV/AIDS Network Coordination (HANC) works with the HIV/AIDS Clinical Trials Networks of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and vaccines.
A new version of the IT Security Best Practices (v5.0) is now published under Data Management & IT Resources. The IT Security Best Practices document outlines a recommended approach for NIH HIV/AIDS Clinical Trials Network research sites and labs to manage information technology and cybersecurity risks. This document was developed by the HANC-facilitated IT Best Practices Working Group (ITBPWG), whose members include the DAIDS, SCHARP, Frontier Science, NIH Office of Cyber Infrastructure and Computational Biology (OCICB), and HANC.
The University of California, San Francisco, Center for AIDS Prevention Studies (CAPS) announces the Ujima Mentoring Program (Ujima Program). Funded by the National Institutes of Mental Health (NIMH) AIDS Research Centers (ARC) Program, the Ujima Program provides multidisciplinary research mentoring and funding to early-stage investigators, particularly those at Historically Black Colleges and Universities (HBCUs), who focus their programs of research on high priority areas that address HIV prevention, care, and treatment in Black/African American communities. Applications are due by February 11th, 2022 at 11.59 pm Pacific Standard Time.
The Office of HIV/AIDS Network Coordination (HANC) programs are referred to as areas of coordination. Within each area of coordination are numerous work groups that are integral to advancing the research goals and objectives defined by the HIV/AIDS Clinical Trials Networks and the Division of AIDS.
HANC supports a number of trans-institute behavioral science groups composed of experts that are working to advance research and clinical trials through cross-network collaboration.
HANC supports Community Partners, The Legacy Project, and the COVID-19 CAB coalition to achieve representation and build relationships with historically underrepresented communities in clinical research.
HANC supports cross-network working groups for network leadership, communications, data management centers, performance evaluation, and site coordinators to promote greater information sharing, collaboration, and process standardization.
HANC supports several cross-network laboratory working groups and committees with the aim of harmonizing processes and procedures, ensuring standard quality assurance for protocol-specified assays and laboratory preparedness for network clinical trials.
The Conference on Retroviruses and Opportunistic Infections (CROI) was established to provide a forum for basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases. Attendance at the conference is open to researchers and clinical educators actively involved in the study and management of HIV, other retroviruses, and related medical conditions.
Working together, we can be the generation to end the HIV/AIDS epidemic. Know the facts, spread the word, volunteer for a study, or join a community advisory board.